Dolby Laboratories, Inc.
DLB
$61.06
-$3.44-5.33%
NYSE
| 12/26/2025 | 09/26/2025 | 06/27/2025 | 03/28/2025 | 12/27/2024 | |
|---|---|---|---|---|---|
| Net Income | 8.10% | 7.08% | -49.81% | 35.34% | 15.80% |
| Total Depreciation and Amortization | 9.11% | 0.73% | -0.12% | -3.06% | 3.34% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -48.92% | 169.15% | -9.62% | -16.34% | -10.73% |
| Change in Net Operating Assets | -364.50% | 52.22% | -175.91% | 306.40% | -3,856.45% |
| Cash from Operations | -55.39% | 81.46% | -61.30% | 63.79% | -8.08% |
| Capital Expenditure | 71.51% | -152.71% | 6.80% | -1.74% | 8.13% |
| Sale of Property, Plant, and Equipment | -- | -- | -100.00% | -- | -- |
| Cash Acquisitions | -- | -- | -- | 100.00% | 99.72% |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 203.62% | -- | -100.00% | -- | -- |
| Cash from Investing | 105.68% | -240.88% | -124.82% | 418.08% | 96.88% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 184.15% | -60.05% | 216.54% | -82.10% | 2,994.55% |
| Repurchase of Common Stock | -172.90% | 9.98% | -12.03% | 22.49% | -119.13% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -8.71% | 0.14% | 0.62% | -0.89% | -10.28% |
| Other Financing Activities | -37.44% | 14.96% | -94.19% | 67.43% | 93.00% |
| Cash from Financing | -90.20% | -5.46% | 6.37% | -12.68% | 4.24% |
| Foreign Exchange rate Adjustments | 92.54% | -101.18% | 106.00% | 138.62% | -263.37% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -278.81% | 491.40% | -95.51% | 309.04% | 116.88% |